Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.
Saved in:
| Title: | Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study. |
|---|---|
| Authors: | Mocci, Giammarco1 (AUTHOR) moccigiammarco@gmail.com, Tursi, Antonio2,3 (AUTHOR), Scaldaferri, Franco3,4 (AUTHOR), Napolitano, Daniele4 (AUTHOR), Pugliese, Daniela3,4,5 (AUTHOR), Maconi, Giovanni5,6 (AUTHOR), Cataletti, Giovanni5,7 (AUTHOR), Pica, Roberta6,8 (AUTHOR), Cassieri, Claudio6,9 (AUTHOR), Savarino, Edoardo Vincenzo7,10 (AUTHOR), De Barba, Caterina7,11 (AUTHOR), Costa, Francesco8,12 (AUTHOR), Ceccarelli, Linda8,13 (AUTHOR), Marzo, Manuela9,14 (AUTHOR), Elisei, Walter10,15 (AUTHOR), Monterubbianesi, Rita10,16 (AUTHOR), Faggiani, Roberto10,17 (AUTHOR), Lombardi, Giovanni11,18 (AUTHOR), Patturelli, Marta11,19 (AUTHOR), Ribaldone, Davide Giuseppe12,20 (AUTHOR) |
| Source: | Journal of Clinical Medicine. Nov2025, Vol. 14 Issue 21, p7801. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
